← The Wire
AKTSNasdaq
Aktis Oncology, Inc.
Pharmaceutical Preparations · DE · CIK 2035832
Aktis Oncology develops targeted alpha radiopharmaceuticals for solid tumors, aiming for broad patient access
red 8-K · 90d
$1.21B
Market cap
$30.11
Last close
+2.3%
1D
+21.5%
5D
539K
Volume
Price · last 39 sessions+58.5%
May 4L $18.27 · H $31.15Jun 29
10
Total filings
May 11, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 11, 20268-KResults of OperationsMay 11, 20268-KExecutive Change · Reg FD DisclosureApr 16, 20268-KResults of OperationsMar 30, 202610-K10-KMar 30, 2026SC 13DSC 13DJan 20, 2026SC 13DSC 13DJan 20, 2026SC 13DSC 13DJan 15, 2026SC 13DSC 13DJan 14, 20268-KBylaw AmendmentJan 12, 2026424B4424B4Jan 9, 2026S-1/AS-1/AJan 7, 2026S-1/AS-1/AJan 5, 2026S-1S-1Dec 19, 2025
Insider Activity
◆ Cluster Buy · 6 insidersIn the 90 days to Jan 12, 2026: 6 insiders bought $114.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Nodelman OlegDirector | Buy | 2,077,779 | $18.00 | $37.4M |
| Jan 12, 2026 | Mpm Oncology Innovations Fund LpTenPercentOwner | Buy | 1,112,777 | $18.00 | $20.0M |
| Jan 12, 2026 | Gadicke AnsbertTenPercentOwner | Buy | 1,112,777 | $18.00 | $20.0M |
| Jan 12, 2026 | Vida Ventures Ii-A, LlcTenPercentOwner | Buy | 812,455 | $18.00 | $14.6M |
| Jan 12, 2026 | Kim Helen SusanDirector,TenPercentOwner | Buy | 812,455 | $18.00 | $14.6M |
| Jan 12, 2026 | Foley ToddDirector,TenPercentOwner | Buy | 232,870 | $18.00 | $4.2M |
| Jan 12, 2026 | Nodelman OlegDirector | Buy | 144,443 | $18.00 | $2.6M |
| Jan 12, 2026 | Vida Ventures Ii-A, LlcTenPercentOwner | Buy | 22,545 | $18.00 | $406K |
| Jan 12, 2026 | Kim Helen SusanDirector,TenPercentOwner | Buy | 22,545 | $18.00 | $406K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance